TRIUMPH-2 followed 1,152 adults for 80 weeks. Almost a third on the 12mg dose lost 25% or more, though diarrhoea and nausea were common and the drug is still unapproved.
Recap by typeshit. Full story at Diabetes.co.uk.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Robert Lufkin MD shares the observational data: an average 16.1 kg lost at six months among 7,297 women, with 62.7% reporting side effects.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
On India Today, the two weighed the benefits of GLP-1 medicines against misuse, with concerns raised about cosmetic use for weight loss.
Diabetes.co.uk reports the late-stage result for Lilly's experimental drug in people with type 2 diabetes. Tap through for the trial details.
Loading…